Message from the Director
One in three Canadians, during their lifetime, will experience a brain-related illness, such as depression, schizophrenia, addiction or Alzheimer’s disease.
And while some are successfully treated, too many are not. Current treatments manage symptoms but don't fully address the complex causes of these illnesses. The Campbell Family Mental Health Research Institute of CAMH has put a priority on this urgent need for innovation in mental illness and brain research.
The Campbell Institute is well-positioned to address this need and translate discoveries to clinical care. Our scientists are leaders in their fields, with expertise spanning brain imaging, genetics and molecular science, and state-of-the-art facilities to conduct their research. We are housed in CAMH, Canada’s largest mental health and addictions hospital, serving more than 30,000 patients each year.
As the Institute enters its fifth year, we can report on many successes. We have had ground-breaking discoveries. Institute scientists have published well over 1,000 peer-reviewed publications. To achieve our broader goals, we’ve established important partnerships with other research centres and industry partners.
The Campbell Institute is successfully translating breakthroughs in the lab into new options for patient care. With this pace of progress, we are optimistic that we can offer hope for the future, and reduce the burden mental illness on individuals, families and communities.
Dr. Bruce G. Pollock, MD, PhD, FRCPC
Vice President, Research, CAMH
Director, Campbell Family Mental Health Research Institute